The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Policy Notices

• Consolidated Notice on NCCIH Clinical Trials Policies
  National Center for Complementary and Integrative Health

• Guidance on Posting Informed Consent Forms for AHRQ-Funded Clinical Trials
  Agency for Healthcare Research and Quality

General Notices

• NIDA Provides Technical Assistance to Investigators on Therapeutics Development for Substance Use Disorders
  National Institute on Drug Abuse

• Notice of Pre-Application Webinar for RFA-HD-20-002 "Pediatric HIV AIDS Cohort Study Program Project Grant Applications (P01 Clinical Trial Not Allowed)"
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 

• Infrastructure for NICHD Multisite Clinical Trials
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 

• Notice of Pre-Submission Technical Assistance Webinars and Frequently Asked Questions for NHLBI RFA-HL-20-025 "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3 - Clinical Trial Optional)
  National Heart, Lung, and Blood Institute

• Notice of Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for NHLBI RFA-HL-20-026 "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (RCC) (U24)
  National Heart, Lung, and Blood Institute

• Notice of Pre-Application Webinars for the Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network-2 (RFA-OD-19-026) and Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network-2 (RFA-OD-19-025)
  National Institutes of Health

• NCATS Announces the Cures Acceleration Network Review Board Workshop: Repurposing Off-Patent Drugs: Research & Regulatory Challenges
  National Center for Advancing Translational Sciences

• Request for Information (RFI): Need for Biologic Reagents, Imaging, Genetic and Cognitive Behavioral Assessment Tools to Facilitate the Use of Marmosets in Biomedical Research
  National Institute on Aging
  National Eye Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notice of Changes to Funding Opportunities

• Notice to Terminate National Institute on Alcohol Abuse and Alcoholisms Participation in PA 19-187 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)
  National Institute on Alcohol Abuse and Alcoholism

• Notice of Added Receipt Date for PAR-16-446, NIAMS Clinical Trial Planning Grant (R34)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases

• Notice to Extend the Expiration Date of PA-16-443 "Drug Abuse Dissertation Research (R36)"
  National Institute on Drug Abuse

• Notice of NIGMS Withdrawal of Participation from PAR-18-630 "Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)"
  National Institute of General Medical Sciences

• Notice of NHGRI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
  National Human Genome Research Institute

• Notice of Change to PAR-20-027, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed)"
  National Institute of Mental Health

• Notice of Change to Foreign Component Eligibility in RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)"
  National Institute of Mental Health

• Notice of Change in Expiration Date of PAR-19-267 "HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)"
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

• Notice of Extension of the Expiration Date for PAR-17-144 "Limited Competition: National Primate Research Centers (P51)"
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
  National Institute of General Medical Sciences

• Notice of Intent to Publish a Funding Opportunity Announcement for Pilot Effectiveness Trials for Rapid-Acting Interventions for Severe Suicide Risk (R01 Clinical Trial Required)
  National Institute of Mental Health

• Notice of Intent to Publish the Reissuance of a Funding Opportunity Announcement for Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (U54)
  National Institute of Neurological Disorders and Stroke

• Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse

• Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences

Requests for Proposal

• Pre-Solicitation Notice: Preclinical Services for HIV Therapeutics, RFP: 75N93019R00021
  National Institute of Allergy and Infectious Diseases

Notices of Special Interest

• Notice of Special Interest (NOSI): Use of Biological Information to Understand How the Interplay of Environmental Exposures and Genes Influences Cancer Risk
  National Cancer Institute

• Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Center for Advancing Translational Sciences
  National Institute of Biomedical Imaging and Bioengineering

• Notice of Special Interest: Research on Emergency Medical Services for Children (EMSC)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 

• Notice of Special Interest: Understanding the biology of iodine nutrition, assessment, and outcomes in women, infants, and children (R01, R21, R03)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 

• Notice of Special Interest (NOSI): Epidemiologic Studies to Characterize Cardiovascular Health and its Predictors and Trajectories in Diverse Groups of Children
  National Heart, Lung, and Blood Institute

Funding Opportunities

• Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)
  Agency for Healthcare Research and Quality
    
  
   
• Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
    
  
   
• Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed)
• Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed)
• Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)
  National Institute on Aging
  
   
• Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
  
   
• Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed)
  National Institute of Allergy and Infectious Diseases
  
   
• Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Screening (R43/R44 Clinical Trial Not Allowed)
  National Institute of Environmental Health Sciences
  
   
• Pediatric HIV/AIDS Cohort Study (PHACS) 2020 (P01 Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  
  
   
• Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 Clinical Trial Optional)
  National Institute of Nursing Research

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or email Lynn Hudachek at lynn-hudachek @uiowa.edu